CLPT Q3 2020 Earnings — ClearPoint Neuro, Inc. Revenue & Financial Results | Market Cap Arena

CLPTClearPoint Neuro, Inc.

$344M

Q3 2020 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$4M+20.2% YoY

Gross Profit

$3M74.3% margin

Operating Income

-$1M-36.1% margin

Net Income

-$1M-42.2% margin

EPS (Diluted)

$-0.09

QoQ Revenue Growth

+42.0%

Cash Flow

Operating Cash Flow

-$1M

Free Cash Flow

-$1M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$22M

Total Liabilities

$22M

Stockholders' Equity

$149,100

Cash & Equivalents

$15M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4M	$3M	+20.2%
Gross Profit	$3M	$2M	+34.5%
Operating Income	-$1M	-$910,529	-39.7%
Net Income	-$1M	-$1M	-32.1%

Revenue Segments

Biologics and Drug Delivery Revenue Subtotal

$1M83%

Capital Equipment and Software Revenue Subtotal

$204,55911%

Therapy Revenue Subtotal

$103,8006%